logo

For the Inventor, By the Inventor

Bures-sur-Yvette, France

Reinhard Fleer

This inventor holds 21 USPTO granted patents, plus 1 CIPO patent, primarily in Fusion Protein Therapeutics. Top assignees: Aventis Behring Gmbh, Rhone-Poulenc Rorer S.a., Novozymes Biopharma UK Limited. Active years: 1997-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard Fleer. Retrieved from https://idiyas.com/inventor/reinhard-fleer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 47.6


Average Co-Inventor Count = 4.2

ph-index = 16

Forward Citations = 1,097(Granted Patents)


Location History:

  • 91440 Bures-sur-Yvette, FR (1999)
  • Gif sur Yvette, FR (2000)
  • Bures sur Yvette, FR (1997 - 2008)
  • Bure-sur-Yvette, FR (2010)

Company Filing History:

goldMedal8 out of 57 
 
Aventis Behring Gmbh
 patents
silverMedal8 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents
bronzeMedal2 out of 4 
 
Novozymes Biopharma UK Limited
 patents
4. 1 out of 16 
 
Novozymes Biopharma Dk A/s
 patents
5. 1 out of 190 
 
Rhone-Poulenc, Inc.
 patents
6. 1 out of 834,513 
Other
 patents

Years Active: 1997-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Fusion Proteins
Albumin
Insulin
Erythropoietin
Interferon
G-CSF
Therapeutic Polypeptides
Recombinant Yeast
Nucleic Acids
Modified Fungal Cells
Yeast Promoters
Therapeutic Functions
21 patents (USPTO):Explore Patents
1. 7833521 - Methods of treating using hormone-albumin fusion proteins (2010-11-16),
2. 7435410 - Methods of treatment with interferson and albumin fusion protein (2008-10-14),
3. 7410779 - Fusion polypeptides of human serum albumin and a therapeutically active polypeptide (2008-08-12),
4. 7094577 - Insulin and albumin fusion protein (2006-08-22),
5. 7081354 - Interleukin and albumin fusion protein (2006-07-25),
6. 7056701 - Hormone and albumin fusion protein (2006-06-06),
7. 7041478 - G-CSF and albumin fusion protein (2006-05-09),
8. 6989365 - Methods of treatment with erythropoietin and albumin fusion protein (2006-01-24),
9. 6987006 - Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof (2006-01-17),
10. 6972322 - Interferon and albumin fusion protein (2005-12-06),
11. 6686179 - Fusion polypeptides of human serum albumin and a therapeutically active polypeptide (2004-02-03),
12. 6165470 - Albumin derivatives with therapeutic functions (2000-12-26),
13. 5876969 - Fusion polypeptides comprising human serum albumin, nucleic acids (1999-03-02),
14. 5821038 - Yeast with modified permeability (1998-10-13),
15. 5714377 - Modified fungal cells and method for producing recombinant products (1998-02-03),

Title: The Innovative Mind of Reinhard Fleer

Introduction: Reinhard Fleer, a pioneering inventor based in Bures-sur-Yvette, France, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Reinhard Fleer holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced electronics. His most recent patent focuses on a revolutionary method for harnessing solar energy efficiently in urban environments.

Career Highlights: With a career spanning over two decades, Reinhard Fleer has consistently pushed the boundaries of innovation. He has worked with leading research institutions and universities to develop cutting-edge solutions for complex technological challenges.

Collaborations: Reinhard Fleer has collaborated with top companies in the renewable energy sector, partnering with like-minded professionals to bring his visionary ideas to life. His collaborative efforts have resulted in the successful implementation of sustainable technologies in various industries.

Conclusion: Reinhard Fleer's passion for innovation and his relentless pursuit of technological advancement have solidified his reputation as a trailblazer in the world of inventors. His work continues to inspire future generations of innovators to think boldly and push the limits of what is possible in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…